[Cancerogenic effect of 1-(p-carboxyethylphenyl)-3,3-dimethyltriazene after s.c. and i.v. administration in rats].
D000818:Animals; D001565:Benzoates / Q000008:administration & dosage; D002273:Carcinogens / Q000008:administration & dosage*; D005260:Female; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007680:Kidney Neoplasms / Q000139:chemically induced; D007942:Leukemia, Experimental / Q000139:chemically induced; D008175:Lung Neoplasms / Q000139:chemically induced; D008228:Lymphoma, Non-Hodgkin / Q000139:chemically induced; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced*; D051381:Rats; D014226:Triazenes / Q000008:administration & dosage*
D001565:Benzoates; D002273:Carcinogens; D014226:Triazenes
Kanzerogene Wirkung von 1-(p-Carboxyäthylphenyl)-3,3-dimethyltriazen nach s.c. und i.v. Gabe bei Ratten.